Gene delivery with synthetic (non viral) carriers.

Non-viral gene delivery involving the use of cationic polymer and cationic lipid based carriers still continues to enjoy a high profile due to the safety advantages offered by these systems when compared with viruses. However, there are still problems associated with the use of these agents, notably their comparatively low efficiency and the inability to target gene expression to the area of pathology. On intravenous administration gene expression is found predominantly in the first capillary bed encountered-the lung endothelium. The clinical use of non-viral gene delivery systems in cystic fibrosis or cancer has involved their direct application to the site of pathology due to the targeting difficulties experienced. For gene expression to occur genes must be transported to the interior of the cell nucleus and a number of biological barriers to effective gene delivery have been identified. These may be divided into extracellular such as the targeting barrier mentioned above and intracellular such as the need for endosomal escape after endocytosis and the inefficient trafficking of genes to the nucleus. Targeting ligands have been used with moderate success to overcome the targeting barrier while endosomal escape and nuclear targeting peptides are some of the strategies, which have been employed to overcome the problems of endosomal escape and nuclear trafficking. It is hoped that the next generation of carriers will incorporate mechanisms to overcome these barriers thus improving the efficacy of such materials.

[1]  A. Takayanagi,et al.  A novel gene delivery system using EGF receptor‐mediated endocytosis , 1994, FEBS letters.

[2]  D. Liggitt,et al.  Topical gene delivery to murine skin. , 1999, The Journal of investigative dermatology.

[3]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[5]  G. Remuzzi,et al.  Nonviral gene delivery to the rat kidney with polyethylenimine. , 1997, Human gene therapy.

[6]  D. M. Carlson,et al.  Gene expression following direct injection of DNA into liver. , 1994, Human gene therapy.

[7]  K. Ulbrich,et al.  A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression , 2000, Gene Therapy.

[8]  J. Baker,et al.  Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Meade,et al.  Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. , 1995, Bioconjugate chemistry.

[10]  G. Merlo,et al.  Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.

[11]  F. Zhang,et al.  A transfecting peptide derived from adenovirus fiber protein , 1999, Gene Therapy.

[12]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[13]  Y. Song,et al.  Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. , 1997, Human gene therapy.

[14]  S. Simões,et al.  Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides , 1998, Gene Therapy.

[15]  T. Matsuo,et al.  Gene transfer to the retina of rat by liposome eye drops. , 1996, Biochemical and biophysical research communications.

[16]  H. Strey,et al.  Improved DNA: liposome complexes for increased systemic delivery and gene expression , 1997, Nature Biotechnology.

[17]  J. Behr,et al.  In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. , 1997, Bioconjugate chemistry.

[18]  B. Meyrick,et al.  Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. , 1994, American journal of respiratory cell and molecular biology.

[19]  M. Merville,et al.  Similar Efficiency of DNA-Liposome Complexes and Retrovirus-Producing Cells for HSV-tk Suicide Gene Therapy of Peritoneal Carcinomatosis , 2000, Journal of drug targeting.

[20]  S. Nir,et al.  Kinetic analysis of the initial steps involved in lipoplex--cell interactions: effect of various factors that influence transfection activity. , 2001, Biochimica et biophysica acta.

[21]  C H Wu,et al.  Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. , 1987, The Journal of biological chemistry.

[22]  E. Nabel,et al.  Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. , 1994, Human gene therapy.

[23]  J. Baker,et al.  The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. , 1997, Biochimica et biophysica acta.

[24]  D. Gill,et al.  A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis , 1997, Gene Therapy.

[25]  J. Behr,et al.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. , 1996, Gene therapy.

[26]  K. Mechtler,et al.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Macilwain World leaders heap praise on human genome landmark , 2000, Nature.

[28]  D. Papahadjopoulos,et al.  Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery , 1997, FEBS letters.

[29]  L. Barrett,et al.  Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery , 1999, Gene Therapy.

[30]  T. Park,et al.  Poly(DMAEMA-NVP)-b-PEG-galactose as gene delivery vector for hepatocytes. , 2000, Bioconjugate chemistry.

[31]  H. Farhood,et al.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.

[32]  M. Buchberger,et al.  Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery , 1997, Gene Therapy.

[33]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[34]  D. Perry,et al.  Novel cationic lipidic peptide dendrimer vectors in vitro gene delivery , 1999 .

[35]  G. Levi,et al.  Optimisation of polyethylenimine-based gene delivery to mouse brain. , 1999, Journal of drug targeting.

[36]  T. Allen,et al.  Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. , 1996, Cancer gene therapy.

[37]  Y. Buechler,et al.  Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)* , 1996, The Journal of Biological Chemistry.

[38]  D. Liggitt,et al.  Aerosol gene delivery in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. D. Brown,et al.  Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. , 2000, Bioconjugate chemistry.

[40]  G. Gregoriadis,et al.  Liposome‐mediated DNA vaccination , 1997, FEBS letters.

[41]  D. Curiel,et al.  Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen , 1998, Gene Therapy.

[42]  A. Kabanov,et al.  Efficient transformation of mammalian cells using DNA interpolyelectrolyte complexes with carbon chain polycations. , 1993, Bioconjugate chemistry.

[43]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[44]  Y. Ohya,et al.  Design of macromolecular biological response modifier by immobilizing of D-glucose analogue of muramyl dipeptide on carboxymethyl-dextran having mannose branches. , 1997, Journal of biomaterials science. Polymer edition.

[45]  T. Ochiya,et al.  Evaluation of cationic liposome suitable for gene transfer into pregnant animals. , 1999, Biochemical and biophysical research communications.

[46]  A. Schatzlein,et al.  Non-viral vectors in cancer gene therapy: principles and progress , 2001, Anti-cancer drugs.

[47]  L. Huang,et al.  Lipophilic polylysines mediate efficient DNA transfection in mammalian cells. , 1991, Biochimica et biophysica acta.

[48]  D. Scherman,et al.  Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. , 1999, Nucleic acids research.

[49]  D W Pack,et al.  Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Wenjin Guo,et al.  Efficient Gene Delivery Using Anionic Liposome-Complexed Polyplexes (LPDII) , 2000, Bioscience reports.

[51]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[52]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[53]  E. Brambilla,et al.  An electron microscopy study into the mechanism of gene transfer with lipopolyamines. , 1996, Gene therapy.

[54]  C. Wu,et al.  Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. , 1994, Nucleic acids research.

[55]  P. Cullis,et al.  Stabilized Plasmid–Lipid Particles: Pharmacokinetics and Plasmid Delivery to Distal Tumors following Intravenous Injection , 2000, Journal of drug targeting.

[56]  A. Surovoy,et al.  A novel series of serum-resistant lipoaminoacid compounds for cellular delivery of plasmid DNA. , 1998, Advances in experimental medicine and biology.

[57]  S. Ferrari,et al.  Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. , 1999, Biochimica et biophysica acta.

[58]  N. Armstrong,et al.  Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. , 1997, Human gene therapy.

[59]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[60]  J. Behr,et al.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Connors Ta The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. , 1995 .

[62]  D J Porteous,et al.  Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. , 1996, Gene therapy.

[63]  M. Ariatti,et al.  Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid. , 2001, Drug delivery.

[64]  G. Mclachlan,et al.  Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis , 1997, Gene Therapy.

[65]  Y. Ohya,et al.  Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool , 1996 .

[66]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[67]  P. Gariglio,et al.  Spermidine-condensed DNA and cone-shaped lipids improve delivery and expression of exogenous DNA transfer by liposomes. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[68]  L. Babiuk,et al.  Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. , 1999, Virology.

[69]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[70]  M. Cotten,et al.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus , 2000, Gene Therapy.

[71]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[72]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[73]  W. Zimmer,et al.  Cell-specific nuclear import of plasmid DNA , 1999, Gene Therapy.

[74]  T. Kondo,et al.  Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain. , 1997, Biochemical and biophysical research communications.

[75]  Teruhiko Yoshida,et al.  Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity , 2001, Gene Therapy.

[76]  N. Phillips,et al.  Major limitations in the use of cationic liposomes for DNA delivery , 1998 .

[77]  D. Weiner,et al.  Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. , 1999, Clinical immunology.

[78]  C. Sirlin,et al.  Gene transfer with a series of lipophilic DNA-binding molecules. , 1994, Bioconjugate chemistry.

[79]  R. Macdonald,et al.  Diquaternary ammonium compounds as transfection agents. , 2001, Bioconjugate chemistry.

[80]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[81]  D A Lauffenburger,et al.  Optimization of Cell Surface Binding Enhances Efficiency and Specificity of Molecular Conjugate Gene Delivery* , 1998, The Journal of Biological Chemistry.

[82]  F. Szoka,et al.  Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. , 1999, Human gene therapy.

[83]  A. Mikos,et al.  Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. , 2001, Biomaterials.

[84]  D. Porteous,et al.  What the papers say: Cystic fibrosis: Prospects for therapy , 1993 .

[85]  N. Weiner,et al.  Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. , 2000, Biomaterials.

[86]  A. Stopeck,et al.  Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes. , 1998, Cancer gene therapy.

[87]  T. Shangguan,et al.  A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA , 2000, Gene Therapy.

[88]  E. Alton Towards Gene Therapy For Cystic Fibrosis * , 1995, The Journal of pharmacy and pharmacology.

[89]  Y. Song,et al.  Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. , 1998, Biochimica et biophysica acta.

[90]  E. Nabel,et al.  A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. , 1996, Human gene therapy.

[91]  A. R. Klemm,et al.  Effects of polyethyleneimine on endocytosis and lysosome stability. , 1998, Biochemical pharmacology.

[92]  R. Müller,et al.  In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers , 2000, The journal of gene medicine.

[93]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[94]  W. Wels,et al.  Target Cell-specific DNA Transfer Mediated by a Chimeric Multidomain Protein , 1996, The Journal of Biological Chemistry.

[95]  J. Park,et al.  Effect of Poly(ethylene glycol)Grafting on Polyethylenimine as a Gene Transfer Vector in vitro , 2001 .

[96]  L. Tetley,et al.  Polymeric Chitosan‐based Vesicles for Drug Delivery , 1998, The Journal of pharmacy and pharmacology.

[97]  E. Brambilla,et al.  In vivo delivery to tumors of DNA complexed with linear polyethylenimine. , 1999, Human gene therapy.

[98]  S. Durham,et al.  Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis , 1995, Nature Medicine.

[99]  K. Anwer,et al.  Optimization of Cationic Lipid/DNA Complexes for Systemic Gene Transfer to Tumor Lesions , 2000, Journal of drug targeting.

[100]  T. Anchordoquy,et al.  Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. , 2000, Biochimica et biophysica acta.

[101]  K. Rice,et al.  A Potent New Class of Reductively Activated Peptide Gene Delivery Agents* , 2000, The Journal of Biological Chemistry.

[102]  S. W. Kim,et al.  pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. , 2000, Bioconjugate chemistry.

[103]  T. Kitagawa,et al.  A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. , 2000, Biochimica et biophysica acta.

[104]  S. Andò,et al.  Characteristics and biodistribution of cationic liposomes and their DNA complexes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[105]  K. Ulbrich,et al.  Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin* , 2000, The Journal of Biological Chemistry.

[106]  Y. Tan,et al.  Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[107]  L. Huang,et al.  Direct gene transfer to mouse melanoma by intratumor injection of free DNA. , 1996, Gene therapy.

[108]  D. Liggitt,et al.  Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.

[109]  A. Kabanov,et al.  Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents , 2000, Gene Therapy.

[110]  P. Felgner,et al.  Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes. , 1996, Biochimica et biophysica acta.

[111]  H. Schreier,et al.  Cationic liposome plasmid DNA complexes : In vitro cell entry and transgene expression augmented by synthetic signal peptides , 1996 .

[112]  K. Anwer,et al.  Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration , 2000, Gene Therapy.

[113]  S. Henry,et al.  Protection against Mycobacterium aviumby DNA Vaccines Expressing Mycobacterial Antigens as Fusion Proteins with Green Fluorescent Protein , 1999, Infection and Immunity.

[114]  J. Hagstrom,et al.  pH-sensitive, cationic liposomes: A new synthetic virus-like vector , 1996, Nature Biotechnology.

[115]  S. Hui,et al.  Electroporation-enhanced gene delivery in mammary tumors , 2000, Gene Therapy.

[116]  J. Isaacs,et al.  Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium , 1999, Gene Therapy.

[117]  J. Behr,et al.  Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway , 1999, Gene Therapy.

[118]  K. Heider,et al.  Polycation‐based DNA complexes for tumor‐targeted gene delivery in vivo , 1999, The journal of gene medicine.

[119]  I. Gluzman,et al.  Transfer of genes into Plasmodium falciparum by polyamidoamine dendrimers. , 1999, Molecular and biochemical parasitology.

[120]  S. Kawakami,et al.  Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. , 1998, Biochemical and biophysical research communications.

[121]  A. Miller,et al.  Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice , 1993 .

[122]  L. Stewart,et al.  Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery , 2000, Gene Therapy.

[123]  M. Hashida,et al.  Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system , 2000, Gene Therapy.

[124]  H. D. Liggitt,et al.  Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery , 1997, Nature Biotechnology.

[125]  F. Szoka,et al.  Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes , 1999, Gene Therapy.

[126]  S. Ferrari,et al.  ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.

[127]  Xiang Gao,et al.  Cationic liposome-mediated gene transfer. , 1995, Gene therapy.

[128]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Hartikainen,et al.  Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. , 2000, Human gene therapy.

[130]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[131]  P. Low,et al.  Measurement of endosome pH following folate receptor-mediated endocytosis. , 1996, Biochimica et biophysica acta.

[132]  D. Gewirtz,et al.  Sustained enhancement of liposome-mediated gene delivery and gene expression in human breast tumour cells by ionizing radiation. , 1999, International journal of radiation biology.

[133]  M. Monsigny,et al.  Efficient gene transfer by histidylated polylysine/pDNA complexes. , 1999, Bioconjugate chemistry.

[134]  S. Parker,et al.  Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. , 1999, Journal of immunology.

[135]  A. Caminade,et al.  PREPARATION OF WATER-SOLUBLE CATIONIC PHOSPHORUS-CONTAINING DENDRIMERS AS DNA TRANSFECTING AGENTS , 1999 .

[136]  J. Baker,et al.  DNA complexing with polyamidoamine dendrimers: implications for transfection. , 1999, Bioconjugate chemistry.

[137]  F. Szoka,et al.  Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. , 1995, Gene therapy.

[138]  M. Zern,et al.  Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents. , 2001, Bioconjugate chemistry.

[139]  Leaf Huang,et al.  Lipidic vector systems for gene transfer. , 1997, Critical reviews in therapeutic drug carrier systems.

[140]  R. Malone,et al.  Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. , 1996, Gene therapy.

[141]  Simon C Watkins,et al.  Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. , 2000, Journal of pharmaceutical sciences.

[142]  L. Greco,et al.  Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. , 1996, Cancer detection and prevention.

[143]  Manmohan J. Singh,et al.  Cationic microparticles: A potent delivery system for DNA vaccines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[144]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[145]  E. Canning,et al.  A triploblast origin for Myxozoa? , 1998, Nature.

[146]  J. Behr,et al.  Liver‐directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo , 1998, Journal of viral hepatitis.

[147]  E. Nabel,et al.  Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[148]  F. Szoka,et al.  Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes , 1999, Gene Therapy.

[149]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[150]  R. Levy,et al.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.

[151]  M. Nango,et al.  Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine , 2000, Gene Therapy.

[152]  Teruhiko Yoshida,et al.  Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. , 1995, Cancer research.

[153]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[154]  R. Perez-soler,et al.  Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer , 2000, Cancer Gene Therapy.

[155]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[156]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[157]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[158]  P. Cullis,et al.  Influence of cholesterol on the association of plasma proteins with liposomes. , 1996, Biochemistry.

[159]  L. Tsui,et al.  Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy , 1998, Gene Therapy.

[160]  Dexi Liu,et al.  Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA , 1998, Gene Therapy.

[161]  T Sakthivel,et al.  DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. , 2000, International journal of pharmaceutics.

[162]  M. Bally,et al.  Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. , 2000, Journal of pharmaceutical sciences.

[163]  S. Simões,et al.  Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH‐sensitive peptides , 1999, Journal of leukocyte biology.

[164]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[165]  K. Fisher,et al.  The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. , 1997, The Biochemical journal.

[166]  A. Takayanagi,et al.  Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery. , 1996, Cancer gene therapy.

[167]  A. Boletta,et al.  Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs , 1999, Gene Therapy.

[168]  F. Sorgi,et al.  In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. , 1996, Gene therapy.